Stockreport

Here's Why We're Watching Prelude Therapeutics' (NASDAQ:PRLD) Cash Burn Situation [Yahoo! Finance]

Prelude Therapeutics Incorporated  (PRLD) 
PDF For example, biotech and mining exploration companies often lose money for years before finding success with a new treatment or mineral discovery. But while the successe [Read more]